Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Natpara
Pharma
J&J-Legend, Takeda, Merck and more—Fierce Pharma Asia
J&J and Legend double down on CAR-T production. Takeda stops making Natpara. Merck builds new facilities in Singapore.
Angus Liu
Oct 7, 2022 10:50am
Takeda is calling it quits on Natpara's US commercial return
Oct 4, 2022 2:35pm
Trade secret suit, Lilly-Innovent, Aurobindo—Fierce Pharma Asia
Mar 25, 2022 9:00am
Takeda's Japan plant reemerges from FDA warning letter
Oct 28, 2021 10:05am
Takeda-CSL, Daiichi, Legend-J&J and more—Fierce Pharma Asia
Apr 9, 2021 10:25am
Takeda eyes March 2022 for Natpara's return to market
Apr 5, 2021 2:53pm
